A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma
BeiGene
BeiGene
Istari Oncology, Inc.
Lumos Pharma
AbbVie
Celgene
Eli Lilly and Company
Novartis
INSYS Therapeutics Inc